Latest Breaking News On - Wayne saville - Page 1 : comparemela.com

Biosion s Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC)

- First clinical trial to evaluate the safety and efficacy of OBI-992 (a.k.a BSI-992), a novel antibody drug conjugate (ADC) targeting TROP2- Dosing of first

Hughm davisWayne savilleHeidi wangBiosion syntracerAdagloxad simoleninBiosion incPharma incBusiness developmentBiosion united states incDrug administrationHigh throughput endocytosis platformChief businessDevelopment officerBiosion united statesChief medical officerChief executive officer

OBI Pharma Inc : OBI Pharma Announces U S FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

OBI Pharma Inc : OBI Pharma Announces U S FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

T ai peiAdagloxad simoleninWayne savilleKevin poulosHeidi wangPharma incDrug administrationFutures bureauBiosion incChief medical officerChief executive officerPrivate securities litigation reform actTaiwan securities

OBI Pharma Announces U S FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

OBI Pharma Announces U S FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

T ai peiKevin poulosWayne savilleHeidi wangAdagloxad simoleninBiosion incPharma incDrug administrationFutures bureauChief medical officerChief executive officerPrivate securities litigation reform actTaiwan securities